| Literature DB >> 24748325 |
Macpherson Mallewa, Pam Vallely, Brian Faragher, Dan Banda, Paul Klapper, Mavuto Mukaka, Harriet Khofi, Paul Pensulo, Terrie Taylor, Malcolm Molyneux, Tom Solomon.
Abstract
BACKGROUND: Fever with reduced consciousness is an important cause of hospital admission of children in sub-Saharan Africa, with high mortality. Cerebral malaria, diagnosed when acute Plasmodium falciparum infection and coma are recorded with no other apparent reason, is one important cause. We investigated whether viruses could also be an important cause of CNS infection in such patients, and examined the relative contribution of viral pathogens and malaria parasitaemia.Entities:
Mesh:
Year: 2013 PMID: 24748325 PMCID: PMC3986031 DOI: 10.1016/S2214-109X(13)70060-3
Source DB: PubMed Journal: Lancet Glob Health ISSN: 2214-109X Impact factor: 26.763
FigureTrial profile
Clinical features at presentation and initial investigations by outcome
| Unadjusted | Adjusted | |||||
|---|---|---|---|---|---|---|
| Male sex | 281 (55%) | 225 (54%) | 56 (60%) | 1·3 (0·8–2·0) | 1·2 (0·6–2·0) | |
| Age (months) | 24 (7–51) | 24 (7–48) | 24 (9–72) | .. | .. | |
| Seizures | 204 (40%) | 161 (38%) | 43 (46%) | 1·3 (0·9–2·1) | 2·3 (0·7–8·1) | |
| Unconsciousness | 121 (24%) | 91 (22%) | 30 (32%) | 1·7 (1·0–2·7) | 1·0 (0·4–2·3) | |
| Fever ≥3 days | 188 (37%) | 153 (37 %) | 35 (37%) | .. | .. | |
| Vomiting | 70 (14%) | 57 (14 %) | 13 (14%) | 1·3 (0·6–2·8) | .. | |
| Diarrhoea | 40 (8%) | 32 (8%) | 8 (8%) | 1·4 (0·6–3·3) | .. | |
| Runny nose | 41 (8%) | 35 (8 %) | 6 (6%) | 1·0 (0·4–2·7) | .. | |
| Headache | 36 (7%) | 33 (8%) | 3 (3%) | 0·9 (0·6–1·4) | .. | |
| Temperature ≥39°C | 48 (9%) | 39 (9%) | 9 (10%) | 1·0 (0·5–2·2) | 0·4 (0·1–1·3) | |
| Deep coma | 144 (28%) | 93 (22%) | 51 (54%) | 4·2 (2·6–6·6) | 6·7 (3·3–13·8) | |
| Bulging fontanelle | 12 (2%) | 7 (2%) | 5 (5%) | 3·3 (1·0–10·6) | 1·5 (0·4–6·8) | |
| Neck stiffness | 39 (8%) | 31 (7%) | 8 (9%) | 1·2 (0·5–2·6) | 1·5 (0·5–4·7) | |
| Abnormal chest | 26 (5%) | 18 (4%) | 8 (9%) | 2·1 (1·1–3·8) | 1·6 (0·7–3·8) | |
| Hepatomegaly | 55 (11%) | 43 (10 %) | 12 (13%) | 1·6 (0·7–3·5) | .. | |
| Splenomegaly | 54 (11%) | 47 (11%) | 7 (7%) | 0·7 (0·3–1·6) | .. | |
| Hepatosplenomegaly | 36 (7%) | 31 (7%) | 5 (5%) | 0·8 (0·3–2·1) | .. | |
| Flexor posturing | 9 (2%) | 5 (1%) | 4 (4 %) | 3·7 (1·0–13·9) | 6·7 (0·8–59·3) | |
| Extensor posturing | 6 (1%) | 5 (1 %) | 1 (1%) | 0·9 (0·1–7·7) | 0·2 (0·0–4·0) | |
| Opisthotonus | 12 (2%) | 9 (2%) | 3 (3%) | 1·5 (0·4–5·6) | 0·8 (0·1–6·5) | |
| Observed seizure | 19 (4%) | 13 (3%) | 6 (6%) | 2·0 (0·7–5·2) | 1·4 (0·3–5·7) | |
| CSF opening pressure ≥230 cm | 8 (2%) | 3 (1%) | 5 (5%) | 7·8 (1·8–33·0) | 18·0 (2·7–121·6) | |
| CSF white cell count >5 per μL | 188 (37%) | 152 (36%) | 36 (38%) | 1·4 (0·9–2·4) | 1·6 (0·9–2·8) | |
| HIV status | ||||||
| Positive | 49 (10%) | 32 (8%) | 17 (18%) | 6·6 (2·5–17·4) | 17·1 (4·3–67·3) | |
| Negative | 91 (18%) | 84 (20%) | 7 (7%) | .. | .. | |
| Not known | 373 (73%) | 303 (72 %) | 70 (74%) | 2·8 (1·2–6·3) | 8·6 (2·4–30·9) | |
| Malaria parasitaemia and CNS virus | 45 (9%) | 28 (7%) | 17 (18%) | 4·0 (2·0–8·1) | 1·9 (0·7–5·2) | |
| Malaria parasitaemia and no CNS virus | 118 (23%) | 101 (24%) | 17 (18%) | 1·1 (0·6-2·1) | 0·8 (0·4–1·8) | |
| CNS virus but no malaria parasitaemia | 88 (17%) | 62 (15%) | 26 (28%) | 2·8 (1·6–5·0) | 2·3 (1·1–4·9) | |
| No malaria parasitaemia or CNS virus | 260 (51%) | 226 (54%) | 34 (36%) | 1 | 1 | |
Data are n (%) or median (IQR), unless otherwise stated. CSF=cerebrospinal fluid.
Comparison of children who survived and died.
Significant on univariate analysis.
Significant on multivariate analysis.
Clinical features and initial investigations by virus
| Male sex | 22 (52%) | 7 (58%) | 6 (75%) | 7 (88%) | 12 (75%) | 15 (52%) | 11 (79%) | 8 (57%) | 193 (51%) | |
| Age (months) | 15 (6–48) | 12 (3–15) | 21 (9–26) | 27 (16–51) | 24 (9–42) | 30 (7–78) | 84 (72–132) | 36 (13–72) | 23 (8–48) | |
| Seizures | 19 (45%) | 5 (42%) | 3 (38%) | 3 (38%) | 9 (56%) | 8 (28%) | 6 (43%) | 10 (71%) | 141 (37%) | |
| Unconsciousness | 3 (7%) | 4 (33%) | 1 (13%) | 3 (38%) | 7 (44%) | 8 (28%) | 5 (36%) | 6 (43%) | 84 (22%) | |
| Fever ≥3 days | 16 (38%) | 1 (8%) | 3 (38%) | 3 (38%) | 6 (38%) | 10 (34%) | 0 | 6 (43%) | 143 (38%) | |
| Vomiting | 3 (7%) | 1 (8%) | 1 (13%) | 4 (50%) | 5 (31%) | 4 (14%) | 0 | 1 (7%) | 51 (13%) | |
| Diarrhoea | 4 (10%) | 2 (17%) | 1 (13%) | 0 | 2 (13%) | 1 (3%) | 0 | 1 (7%) | 29 (8%) | |
| Runny nose | 6 (14%) | 2 (17%) | 2 (25%) | 1 (13%) | 3 (19%) | 1 (3%) | 0 | 2 (14%) | 24 (6%) | |
| Headache | 2 (5%) | 0 | 1 (13%) | 3 (38%) | 2 (13%) | 2 (7%) | 0 | 0 | 26 (7%) | |
| Temperature ≥39°C | 3 (7%) | 1 (8%) | 0 | 0 | 1 (6%) | 1 (3%) | 2 (14%) | 1 (7%) | 39 (10%) | |
| Deep coma | 12 (29%) | 6 (50%) | 1 (13%) | 3 (38%) | 7 (44%) | 9 (31%) | 4 (29%) | 5 (36%) | 101 (27%) | |
| Bulging fontanelle | 1 (2%) | 2 (17%) | 0 | 1 (13%) | 3 (19%) | 0 | 0 | 0 | 5 (1%) | |
| Neck stiffness | 2 (5%) | 4 (33%) | 0 | 0 | 1 (6%) | 1 (3%) | 4 (29%) | 1 (7%) | 26 (7%) | |
| Abnormal chest | 6 (14%) | 2 (17%) | 1 (13%) | 1 (13%) | 2 (13%) | 0 | 0 | 2 (14%) | 12 (3%) | |
| Hepatomegaly | 4 (10%) | 1 (8%) | 2 (25%) | 3 (38%) | 3 (19%) | 2 (7%) | 0 | 1 (7%) | 39 (10%) | |
| Splenomegaly | 3 (7%) | 0 | 1 (13%) | 3 (38%) | 2 (13%) | 3 (10%) | 0 | 1 (7%) | 41 (11%) | |
| Hepatosplenomegaly | 3 (7%) | 0 | 1 (13%) | 2 (25%) | 2 (13%) | 1 (3%) | 0 | 1 (7%) | 27 (7%) | |
| Flexor posturing | 0 | 1 (8%) | 0 | 0 | 2 (13%) | 2 (7%) | 0 | 0 | 4 (1%) | |
| Extensor posturing | 0 | 0 | 0 | 0 | 1 (6%) | 1 (3%) | 0 | 0 | 4 (1%) | |
| Opisthotonus | 1 (2%) | 1 (8%) | 0 | 0 | 0 | 0 | 0 | 0 | 10 (3%) | |
| Observed seizure | 5 (12%) | 0 | 0 | 0 | 2 (13%) | 0 | 1 (7%) | 1 (7%) | 12 (3%) | |
| CSF opening pressure ≥230 cm | 0 | 1 (8%) | 0 | 0 | 1 (6%) | 0 | 2 (14%) | 0 | 4 (1%) | |
| CSF white cell count >5 per μL | 11 (26%) | 1 (8%) | 4 (50%) | 2 (25%) | 0 | 11 (38%) | 2 (14%) | 8 (57%) | 149 (39%) | |
| HIV status | ||||||||||
| Positive | 0 | 2 (17%) | 1 (13%) | 0 | 2 (13%) | 2 (7%) | 0 | 2 (14%) | 40 (11%) | |
| Negative | 11 (26%) | 1 (8%) | 1 (13%) | 0 | 7 (44%) | 7 (24%) | 0 | 3 (21%) | 61 (16%) | |
| Not known | 29 (69%) | 6 (50%) | 5 (63%) | 0 | 6 (38%) | 19 (66%) | 14 (100%) | 10 (71%) | 284 (75%) | |
| Malaria parasitaemia and CNS virus | 11 (26%) | 3 (25%) | 0 | 2 (25%) | 5 (31%) | 7 (24%) | 5 (36%) | 8 (57%) | .. | |
| CNS virus but no malaria parasitaemia | 26 (62%) | 5 (42%) | 5 (63%) | 5 (63%) | 7 (44%) | 19 (66%) | 9 (64%) | 6 (43%) | .. | |
| Outcome | ||||||||||
| Sequelae | 4 (10%) | 2 (17%) | 2 (25%) | 0 | 2 (13%) | 3 (10%) | 0 | 2 (14%) | 39 (10%) | |
| Died | 11 (26%) | 10 (83%) | 3 (38%) | 1 (13%) | 1 (6%) | 5 (17%) | 14 (100%) | 3 (21%) | 46 (12%) | |
Data are n (%) or median (IQR). 11 patients (not shown here) had dual virus infections; each patient had a different combination of viruses: adenovirus in five cases, human herpes virus in four, cytomegalovirus in four, enterovirus in three, mumps in three, herpes simplex virus in one, measles in one, and parvovirus in one. Genotyping indicated that seven of the adenoviruses detected were members of subgroup B, one was subgroup C. Median age of patients with dual infection was 18 months (IQR 15–26), and Blantyre coma score on admission 3 (2–5). Seven patients with dual infection had malaria parasitaemia, three were HIV positive (of five tested), and three had a CSF pleocytosis.·Six children (55%) with dual viral infections died. CSF=cerebrospinal fluid.
Epstein-Barr virus (five patients), parvovirus (five), human herpes virus 7 (two), measles (one), JC/BK virus (one).
Clinical features and initial investigation by malaria parasitaemia and viral CNS infection
| CNS virus (n=45) | No CNS virus (n=118) | Unadjusted odds ratio (95% CI) | CNS virus (n=88) | No CNS virus (n=262) | Unadjusted odds ratio (95% CI) | |||
|---|---|---|---|---|---|---|---|---|
| Male sex | 28 (62%) | 60 (51%) | 1·6 (0·7–3·4) | 52 (59%) | 141 (54%) | 1·2 (0·7–2·1) | 0·479 | |
| Age (months) | 34 (9–72) | 30 (15–50) | 1·0 (1·0–1·0) | 23 (6–78) | 14 (6–48) | 1·0 (1·0–1·0) | 0·001 | |
| Seizures | 32 (71%) | 51 (43%) | 3·2 (1·5–7·4) | 30 (34%) | 91 (35%) | 0·97 (0·6–1·7) | <0·0001 | |
| Generalised | 27 (60%) | 37 (31%) | 3·2 (1·5–7·1) | 25 (28%) | 72 (27%) | 1·0 (0·6–1·8) | <0·0001 | |
| Focal | 6 (13%) | 8 (7%) | 2·1 (0·6–7·4) | 3 (3%) | 15 (6%) | 0·6 (0·1–3·0) | 0·172 | |
| Previous history | 8 (18%) | 8 (7%) | 2·6 (0·8–8·0) | 6 (7%) | 19 (7%) | 1·1 (0·4–3·0) | 0·139 | |
| Unconsciousness | 23 (51%) | 44 (37%) | 2·1 (0·8–8·0) | 13 (15%) | 41 (16%) | 1·4 (0·6–3·0) | <0·0001 | |
| Fever ≥3 days | 16 (36%) | 48 (41%) | 1·6 (0·6–3·8) | 29 (33%) | 95 (36%) | 0·9 (0·5–1·8) | 0·719 | |
| Vomiting | 9 (20%) | 20 (17%) | 1·2(0·4–3·1) | 8 (9%) | 33 (13%) | 0·7 (0·3–1·6) | 0·208 | |
| Diarrhoea | 2 (4%) | 10 (8%) | 0·5 (0·1–2·5) | 8 (9%) | 20 (8%) | 1·2 (0·4–3·0) | 0·841 | |
| Runny nose | 6 (13%) | 5 (4%) | 3·5 (0·8–15·1) | 8 (9%) | 22 (8%) | 1·1 (0·4–2·7) | 0·209 | |
| Headache | 2 (4%) | 14 (12%) | 0·3 (0·0–1·6) | 8 (9%) | 12 (5%) | 1·1 (0·4–2·8) | 0·054 | |
| Temperature ≥39°C | 3 (7%) | 19 (16%) | 0·6 (0·4–1·0) | 5 (6%) | 21 (8%) | 1·1 (0·8–1·6) | 0·022 | |
| Deep coma | 27 (60%) | 51 (43%) | 0·5 (0·3–1·0) | 16 (18%) | 50 (19%) | 1·1 (0·8–2·0) | <0·0001 | |
| Bulging fontanelle | 1 (2%) | 1 (1%) | 2·0 (0·1–78·2) | 5 (6%) | 5 (2%) | 3·1 (0·7–13·8) | 0·142 | |
| Neck stiffness | 1 (2%) | 4 (3%) | 0·5 (0·1–4·7) | 6 (7%) | 28 (11%) | 0·6 (0·2–1·6) | 0·044 | |
| Abnormal chest | 3 (7%) | 4 (3%) | 2·0 (0·3–12·5) | 9 (10%) | 10 (4%) | 2·9 (1·0–18·1) | 0·091 | |
| Hepatomegaly | 10 (22%) | 26 (22%) | 0·7 (0·3–2·0) | 5 (6%) | 14 (5%) | 1·1 (0·4–3·5) | <0·0001 | |
| Splenomegaly | 10 (22%) | 22 (19%) | 1·0 (0·4–2·7) | 3 (3%) | 19 (7%) | 0·4 (0·1–1·6) | <0·0001 | |
| Flaccid paralysis | 2 (4%) | 11 (9%) | 0·3 (0·1–1·5) | 1 (1%) | 7 (3%) | 0·4 (0·0–3·3) | <0·0001 | |
| Spastic paralysis | 4 (9%) | 5 (4%) | 2·0 (0·5–8·3) | 6 (7%) | 9 (3%) | 1·9 (0·5–6·8) | 0·442 | |
| Flexor posturing | 3 (7%) | 5 (4%) | 1·4 (0·3–6·3) | 0 | 1 (<1%) | .. | 0·002 | |
| Extensor posturing | 1 (2%) | 2 (2%) | 1·1 (0·1–12·8) | 0 | 3 (1%) | .. | 0·550 | |
| Opisthotonus | 0 | 4 (3%) | .. | 1 (1%) | 7 (3%) | 0·4 (0·0–3·3) | 0·661 | |
| Extensor plantar | 7 (16%) | 16 (14%) | 1·1 (0·4–3·3) | 8 (9%) | 24 (9%) | 1·4 (0·5–3·8) | 0·372 | |
| Observed seizure | 6 (13%) | 6 (5%) | 2·6 (0·7–9·2) | 2 (2%) | 7 (3%) | 0·9 (0·2–4·8) | 0·017 | |
| CSF opening pressure ≥230 cm | 2 (4%) | 5 (4%) | 1·2 (0·2–7·9) | 0 | 1 (<1%) | .. | 0·930 | |
| CSF white cell count >5 per μL | 11 (24%) | 48 (41%) | 0·5 (0·3–1·0) | 31 (35%) | 98 (37%) | 1·1 (0·6–1·8) | 0·501 | |
| HIV positive | 4 (9%) | 10 (8%) | 0·9 (0·2–3·2) | 8 (9%) | 27 (10%) | 0·6 (0·2–1·7) | 0·971 | |
| Outcome | ||||||||
| Died | 17 (38%) | 17 (14%) | 3·6 (1·6–8·0) | 26 (30%) | 34 (13%) | 2·8 (1·6–5·0) | <0·0001 | |
Data are n (%) or median (IQR), unless otherwise stated. CSF=cerebrospinal fluid.
Unadjusted comparison across all four groups.